Brief: Exopharm Says In Aggregate Up To A$1.57M (Before Costs) Is Planned To Be Raised

Entropy Neurodynamics

26/04/2023 02:19

April 26 (Reuters) - Exopharm Ltd  EX1.AX :
    * IN AGGREGATE UP TO AROUND A$1.57M (BEFORE COSTS) IS
PLANNED TO
BE RAISED

Source text for Eikon:  ID:nASX8kDVKT 
Further company coverage:  EX1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))